NuCana PLC (NCNA)
1.23
-0.04
(-3.15%)
USD |
NASDAQ |
Nov 22, 16:00
1.235
0.00 (0.00%)
After-Hours: 20:00
NuCana Free Cash Flow: -22.00M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -22.00M |
| March 31, 2024 | -28.30M |
| December 31, 2023 | -33.49M |
| September 30, 2023 | -43.43M |
| June 30, 2023 | -27.38M |
| March 31, 2023 | -30.29M |
| December 31, 2022 | -29.32M |
| September 30, 2022 | -34.25M |
| June 30, 2022 | -38.24M |
| March 31, 2022 | -34.70M |
| December 31, 2021 | -34.24M |
| September 30, 2021 | -31.40M |
| June 30, 2021 | -37.92M |
| March 31, 2021 | -32.69M |
| Date | Value |
|---|---|
| December 31, 2020 | -29.84M |
| September 30, 2020 | -24.36M |
| June 30, 2020 | -26.62M |
| March 31, 2020 | -32.20M |
| December 31, 2019 | -32.04M |
| September 30, 2019 | -29.98M |
| June 30, 2019 | -25.21M |
| March 31, 2019 | -22.54M |
| December 31, 2018 | -18.48M |
| September 30, 2018 | -18.56M |
| June 30, 2018 | -16.62M |
| March 31, 2018 | -14.80M |
| December 31, 2017 | -12.66M |
Free Cash Flow Range, Past 5 Years
-43.43M
Minimum
Sep 2023
-22.00M
Maximum
Jun 2024
-31.72M
Average
-32.04M
Median
Dec 2019
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics PLC | -56.05M |
| Biodexa Pharmaceuticals PLC | -11.12M |
| TC BioPharm (Holdings) PLC | -15.84M |
| Mereo BioPharma Group PLC | -30.90M |
| Autolus Therapeutics PLC | -205.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.446M |
| Cash from Investing (Quarterly) | -0.0053M |
| Cash from Financing (Quarterly) | -0.0888M |
| Free Cash Flow Per Share (Quarterly) | -0.6922 |
| Free Cash Flow Yield | -828.9% |